SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,019,000 | -90.4% | 25,850 | -79.2% | 0.06% | -91.5% |
| Q4 2020 | $21,141,000 | +178.8% | 124,000 | +129.6% | 0.77% | +96.7% |
| Q3 2020 | $7,583,000 | -74.2% | 54,000 | -70.6% | 0.39% | -86.2% |
| Q2 2020 | $29,406,000 | +67.6% | 183,400 | +2.2% | 2.83% | +35.7% |
| Q1 2020 | $17,549,000 | +24.8% | 179,400 | +64.6% | 2.08% | +68.5% |
| Q4 2019 | $14,065,000 | +86.7% | 109,000 | +9.0% | 1.24% | -3.9% |
| Q3 2019 | $7,532,000 | +256.1% | 100,000 | +525.0% | 1.29% | +51.8% |
| Q2 2018 | $2,115,000 | -6.7% | 16,000 | -68.0% | 0.85% | +27.7% |
| Q3 2017 | $2,268,000 | +124.3% | 50,000 | +66.7% | 0.66% | +65.6% |
| Q2 2017 | $1,011,000 | -58.8% | 30,000 | -25.0% | 0.40% | -46.2% |
| Q3 2016 | $2,456,000 | +25.8% | 40,000 | -60.0% | 0.75% | -16.0% |
| Q1 2016 | $1,952,000 | +838.5% | 100,000 | +1751.9% | 0.89% | +909.1% |
| Q4 2015 | $208,000 | +20.2% | 5,400 | 0.0% | 0.09% | -11.1% |
| Q3 2015 | $173,000 | +5.5% | 5,400 | 0.0% | 0.10% | +17.9% |
| Q2 2015 | $164,000 | +127.8% | 5,400 | 0.0% | 0.08% | +127.0% |
| Q1 2015 | $72,000 | – | 5,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |